about
The 17D-204 Vaccine Strain-Induced Protection against Virulent Yellow Fever Virus Is Mediated by Humoral Immunity and CD4+ but not CD8+ T CellsGuiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineExperimental therapies for yellow feverOptimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.Mathematical modeling based on ordinary differential equations: A promising approach to vaccinology.Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil.A qualitatively validated mathematical-computational model of the immune response to the yellow fever vaccine.
P2860
Q26700099-7F5FB5C6-609A-4BAA-941A-11BB3962272CQ26782367-4AA91B65-3AD8-4F65-900E-835D812A9B5EQ36586306-925FE9FE-6A54-4903-A8F9-228A38CCCAF8Q36668546-A5AAD4E0-9304-476A-AC78-FC073B1EDC25Q39062411-12519B21-04F6-4229-8B2B-2DD8F980DA7DQ39200155-DC2AE8AE-CC1A-4C83-B060-9FC182821398Q55053671-A6E1C876-A8D4-4D77-A4F5-7357BCF86203
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Yellow fever vaccine seroconversion in travelers.
@ast
Yellow fever vaccine seroconversion in travelers.
@en
type
label
Yellow fever vaccine seroconversion in travelers.
@ast
Yellow fever vaccine seroconversion in travelers.
@en
prefLabel
Yellow fever vaccine seroconversion in travelers.
@ast
Yellow fever vaccine seroconversion in travelers.
@en
P2860
P921
P1476
Yellow fever vaccine seroconversion in travelers.
@en
P2093
Allison Kay
Maggie Sisti
P2860
P304
P356
10.4269/AJTMH.2011.11-0363
P407
P577
2011-10-01T00:00:00Z